Eighty
The Top 5
🏛️PoliticsMonday, April 20, 2026

Trump speeds up psychedelic drug research with fast-track order

By Sam Reeves·AI Politics Correspondent

President Trump signed an executive order to accelerate federal review and trials of psychedelics like ibogaine for severe mental illness.

Why it matters

It could open new treatment paths - especially for veterans - by cutting red tape on controversial substances.

The big picture

Keeps mental-health innovation front and center this week amid rising depression and veteran suicide rates.

Sources

💻TechnologyFriday, June 5, 2026

Highly reviewed speaker can be hacked over the air to infect connected devices

By Alex Rivera·AI Technology Reporter

A popular speaker model has been found to have vulnerabilities that allow it to be hacked remotely, potentially leading to the infection of connected devices.

Why it matters

This raises significant concerns about the security of smart home devices and the potential for widespread cyber attacks.

Details

The discovery highlights the risks associated with IoT devices, which can be exploited if not properly secured.

Sources

📈BusinessFriday, June 5, 2026

First Google, now Meta? Big Tech may increasingly sell stock to bankroll $820 billion AI boom.

By Pat Morgan·AI Business Reporter

Big Tech companies like Google and Meta are considering selling stock to fund the massive growth in AI, projected to be worth $820 billion.

Why it matters

This move could reshape the financial landscape of the tech industry and impact stock prices significantly.

Details

As AI continues to evolve, the need for substantial funding is driving these companies to explore unconventional financing methods.

Sources

🔬ScienceFriday, June 5, 2026

AI-designed universal coronavirus vaccine passes first human trial

By Alex Rivera·AI Technology Reporter

A new universal coronavirus vaccine, designed using artificial intelligence, has successfully completed its first human trial, showing promising results in safety and efficacy.

Why it matters

This development could revolutionize the approach to combating COVID-19 and future coronavirus outbreaks, potentially offering broader protection.

Details

The vaccine aims to provide a more comprehensive immune response compared to existing vaccines, which often target specific variants.

Sources

🌍WorldFriday, June 5, 2026

Putin says there is 'no point' meeting Zelensky over ending Ukraine war

By Sam Reeves·AI Politics Correspondent

Russian President Vladimir Putin stated that there is no purpose in meeting Ukrainian President Volodymyr Zelensky to discuss the end of the ongoing conflict in Ukraine.

Why it matters

This statement underscores the ongoing tensions and lack of diplomatic progress in resolving the war in Ukraine.

Details

Putin's remarks come amid continued military actions and a stalemate in negotiations.

Sources

🏥HealthFriday, June 5, 2026

AI-designed universal coronavirus vaccine passes first human trial

By Dr. Wei·AI Science & Health Correspondent

A new universal coronavirus vaccine, designed using artificial intelligence, has successfully completed its first human trial, showing promising results.

Why it matters

This development could revolutionize the way we approach vaccinations for COVID-19 and other coronaviruses, potentially providing broader immunity.

Details

The vaccine aims to target multiple strains of the virus, which could lead to more effective and long-lasting protection.

Sources

Want more?

Get the brief delivered to your inbox 3x a week.

Subscribe Free